Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

FDA Approves Varipulse Pulsed-Field Ablation System for AF

News Daily News

FDA Approves Varipulse Pulsed-Field Ablation System for AF

Michael O'Riordan

November 07, 2024

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

February 02, 2024

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

News Daily News

FDA Approves Portico TAVI Valve, Paving the Way for Third US Device

September 20, 2021

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

News Daily News

Xience Cleared in Europe for 1-Month DAPT in High-Bleeding-Risk Patients

April 06, 2021

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

News Daily News

FDA Approves Harmony TPV for Pulmonary-Valve Regurgitation in Congenital HD

Yael L. Maxwell

March 26, 2021

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

News Daily News

FDA Extends Ticagrelor Indication to High-Risk CAD Primary Prevention

June 01, 2020

News Daily News

FDA Approves Two Generic Versions of Apixaban

December 23, 2019

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

FDA Gives Rivaroxaban Another VTE-Related Indication

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

October 14, 2019

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

News Daily News

FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients

Yael L. Maxwell

May 16, 2019

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

October 12, 2018

FDA Approves New Covered Stent Option for Coronary Perforations

News Daily News

FDA Approves New Covered Stent Option for Coronary Perforations

September 14, 2018

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

News Daily News

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

September 05, 2018

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

News Daily News

Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval

May 04, 2018

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

December 26, 2017

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.